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Instant insight: think outside the cell
Abstract
Proteins perform many different functions critical for life, from building our muscle structure to digesting
our food. These large biological molecules each have a unique three-dimensional shape which they
require to perform their function. In protein deposition diseases (PDDs), however, a disease-specific
protein molecule unfolds from its normal shape and assembles together with like molecules into
insoluble rod-shaped fibrils. These protein deposits can be found in the brain, skeletal tissue and various
organs; in some cases they may become large enough to disrupt tissue structure and function.
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Instant Insight: Think outside the cell
Proteins are large biological molecules which perform many different functions
critical for life (e.g. making up the structure of muscle, digesting our food). They have
a unique three-dimensional shape that is required for them to perform their function.
In protein deposition diseases (PDDs) a disease-specific protein molecule unfolds
from its normal shape and assembles together with many other unfolded molecules of
the same protein to form insoluble rod-like fibrils. One of the most prevalent and
costly PDDs is Alzheimer's disease (AD) but there are more than 40 diseases in this
group including Parkinson's disease, mad cow disease and motor neurone disease.
The protein deposits can be found in the brain, skeletal tissue and various organs; in
some cases they may become large enough to disrupt tissue structure and function.
When it is considered that cells and their surrounds (extracellular spaces) are densely
packed with thousands of different proteins, and are exposed to many stresses capable
of unfolding proteins, it seems miraculous that there are not more of these PDDs.
Inside cells (i.e. intracellularly) there is a large amount of energy invested into
ensuring that proteins reach and maintain their normal (native) shape. This quality
control machinery includes molecular chaperones, which bind to hydrophobic (waterhating) regions normally buried inside the native shape of a protein, and sophisticated
degradation machinery such as the proteasome. There is little doubt that these
intracellular mechanisms protect our bodies from PDDs which would otherwise
produce harmful protein deposits inside cells. But what happens outside cells where
many PDDs, including AD, produce insoluble deposits? The answer to this question
is the focus of our review. Very little previous work has examined this question, being
instead directed towards those now relatively well understood intracellular
mechanisms.
Recently, it was discovered that a small group of human blood proteins possess the
ability to "chaperone" misfolded proteins (i.e. keep them soluble and inhibit their
clumping together). Each of these “extracellular chaperones” (ECs; clusterin,
haptoglobin and 2-macroglobulin) is bound by specific cell surface receptors that
can internalise them and their ligands for subsequent degradation inside the cell. The
ECs and their receptors may comprise the foundation of an extracellular system for
quality control of protein folding. Such a system may be overwhelmed in extracellular
PDDs such as AD. Consistent with the model proposed, it has been shown that in
mouse brains the clearance of extracellular amyloid- peptide (which forms the
plaques in the brain in AD) is much faster when it is bound to clusterin and slower
when 2-macroglobulin or the 2-macroglobulin receptor are inhibited. Studies of the
system(s) sensing and controlling protein folding in extracellular spaces of the body
are in their infancy but in time are likely to produce important insights into the
mechanisms underpinning extracellular PDDs. This will provide new opportunities to
develop therapeutic strategies for a range of diseases that will have an increasing
impact on an ageing world population.

